Rare diseases
Investigational molecules
Locations
74 Rue Du Faubourg Saint Antoine, 75012 Paris, France
Gensight Biologics focuses on Leber Hereditary Optic Neuropathy linked to mutations in the mitochondrial ND4 gene, with research centered on preserving and improving visual acuity in affected patients.
The sponsor’s work in this area is directed toward gene-based ophthalmic treatment for a rare hereditary disorder that causes rapid and severe vision loss.
Gensight Biologics runs clinical trials in conditions such as Hereditary optic atrophy, Retinitis pigmentosa, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
